Theratechnologies Files Material Change Report
| Field | Detail |
|---|---|
| Company | Theratechnologies Inc. |
| Form Type | 6-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-change, regulatory-filing
TL;DR
Theratechnologies filed a 6-K with a material change report on April 1st.
AI Summary
Theratechnologies Inc. filed a Form 6-K on April 1, 2025, reporting a Material Change. The filing includes a Material Change Report dated April 1, 2025, as Exhibit 99.1. The company is incorporated in Canada and its principal executive office is located in Montreal, Quebec.
Why It Matters
This filing indicates a significant event or change within Theratechnologies Inc. that is being disclosed to investors and the market.
Risk Assessment
Risk Level: low — This is a routine filing to report a material change, not indicative of immediate financial distress or significant operational shifts.
Key Players & Entities
- Theratechnologies Inc. (company) — Filer of the report
- April 1, 2025 (date) — Date of the Material Change Report and filing
- Jocelyn Lafond (person) — General Counsel and Corporate Secretary who signed the report
FAQ
What is the nature of the material change reported by Theratechnologies Inc.?
The filing itself does not detail the specific nature of the material change; it only reports that a Material Change Report dated April 1, 2025, has been filed as Exhibit 99.1.
When was this Form 6-K filed?
The Form 6-K was filed on April 1, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at 2015 Peel Street, Suite 1100, Montreal, Quebec H3A 1T8, Canada.
Who signed the Form 6-K on behalf of Theratechnologies Inc.?
Jocelyn Lafond, General Counsel and Corporate Secretary, signed the report on behalf of Theratechnologies Inc.
What is the SIC code for Theratechnologies Inc.?
The Standard Industrial Classification (SIC) code for Theratechnologies Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 1, 2025 by Jocelyn Lafond regarding Theratechnologies Inc..